Disclosure Panels Details Page
Central Nervous System Cancers Panel - Disclosures as of 04/03/2015
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Mario Ammirati MD, MBA | None | None | None | None | ✔ |
| Joachim Baehring MD | Bristol Myers Squibb | Genentech, Inc. | Sigma-Tau Pharmaceuticals, Inc. | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| Henry Brem MD | Johns Hopkins University | AsclepiX Therapeutics Celsion-EGEN Perosphere Inc. StemGen |
None | None | - |
| Paul Brown MD | National Cancer Institute | Novocure | None | None | ✔ |
| Nicholas Butowski MD | None | Roche Laboratories, Inc. | Genentech, Inc. | None | ✔ |
| Marc Chamberlain MD | NCCN Funded Bendamustine trial for Recurrent High-Grade Gliomas | Novartis Advisory Board | None | None | ✔ |
| Anita Engh PhD | None | None | None | None | ✔ |
| Robert Fenstermaker MD | Celgene Corporation MimiVax |
None | None | MimiVax | ✔ |
| Fayna Ferkle PharmD | None | None | None | None | - |
| Allan Friedman MD | None | None | None | None | - |
| Lauren Gallagher | None | None | None | None | - |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Jona Hattangadi-Gluth MD | None | None | None | None | ✔ |
| Matthias Holdhoff MD, PhD | None | None | None | None | ✔ |
| Larry Junck MD | Celldex Northwest Biotherapeutics, Inc. |
None | None | None | ✔ |
| Thomas Kaley MD | None | None | None | None | ✔ |
| Ronald Lawson MD, FACP | None | None | None | None | ✔ |
| Jay Loeffler MD | None | None | None | None | ✔ |
| Mary Lovely | None | None | None | None | ✔ |
| Joan McClure MS | None | None | None | None | - |
| Nicole McMillian MS | None | None | None | None | - |
| Paul Moots MD | ECOG EMD Sereno Novartis Pharmaceuticals Corporation |
None | None | None | ✔ |
| Maciej Mrugala MD, PhD, MPH | None | Novocure Prime Oncology Sigma-Tau Pharmaceuticals, Inc. |
None | None | ✔ |
| Louis Nabors MD | AstraZeneca Pharmaceuticals LP Boehringer Ingelheim GmbH Eli Lilly and Company Genentech, Inc. GSK ImClone Systems Incorporated Merck KGaA Transmolecular |
Merck KGaA | None | None | ✔ |
| Herbert Newton MD | None | Genentech, Inc. Novocure |
Genentech, Inc. Novocure Sigma-Tau Pharmaceuticals, Inc. |
None | ✔ |
| Ian Parney MD, PhD | None | Agenus, Inc. | None | None | ✔ |
| Jana Portnow MD | None | None | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Jeffrey Raizer MD | AbbVie, Inc. CellDex Genentech, Inc. Novartis Pharmaceuticals Corporation |
AbbVie, Inc. Agenus Aurasense Genentech, Inc. Novocure Proximagen Stemline Threshold |
Genentech, Inc. | None | ✔ |
| Lawrence Recht MD | Nektar Therapeutics sanofi-aventis U.S. |
Agneus | None | None | ✔ |
| Nicole Shonka MD | None | None | None | None | ✔ |
| Dennis Shrieve MD, PhD | None | None | BrainLab | None | ✔ |
| Allen Sills MD | None | National Football League | None | None | ✔ |
| Lode Swinnen MBChB | Abbott Laboratories | None | None | None | - |
| David Tran MD, PhD | Celldex Merck & Co., Inc. Northwest Biotherapeutics, Inc. Novocure |
Novocure | Novocure | None | ✔ |
| Nam Tran MD, PhD | None | None | None | None | ✔ |
| Frank Vrionis MD, PhD, MPH | Globus Republic Spine |
Florida Board of Medicine Southeastern Brain Tumor Association |
None | None | ✔ |
| Stephanie Weiss MD | None | None | None | None | ✔ |
| Patrick Wen MD | AstraZeneca Pharmaceuticals LP Genentech, Inc. Immunocellulr Therapeutics Novartis Pharmaceuticals Corporation sanofi-aventis U.S. |
AbbVie, Inc. Cubist Foundation Medicine Genentech, Inc. Midatech Novartis Pharmaceuticals Corporation Novocure Vascular Biogenics |
Merck & Co., Inc. | None | ✔ |